| Date | Title | Description |
| 14.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 13.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 11.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 10.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 09.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 08.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 07.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 03.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 02.10.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 29.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 26.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 23.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 22.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 21.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 20.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 19.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 18.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 14.09.2021 | Truvian Sciences Raises $25M in debt financing to accelerate growth initiatives and to further advance the development of its automated benchtop blood testing system | - |
| 02.03.2021 | Truvian Sciences Receives $105 Million Series C Funding | Truvian Sciences received $105 million in Series C funding for the development of its automated benchtop blood testing system, the company announced on Feb...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a... |
| 25.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
| 24.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
| 24.02.2021 | Truvian Sciences : Raises More Than $105 Million in Oversubscribed Series C Financing | SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- Truvian Sciences ("Truvian") today announced the close of more than $105 million in an oversubscribed Series C financing round led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittin... |
| 24.02.2021 | Truvian Sciences has raised a $105M funding round to pursue FDA approval of its automated blood testing technology by the end of this year | - |
| 24.02.2021 | San Diego’s Truvian Sciences raises $105M to bring common wellness blood tests closer to home | Truvian Sciences, a San Diego startup that’s developing a benchtop blood testing machine to bring rapid, point-of-care health screening to local pharmacies, medical clinics and corporate wellness centers, has raised $105 million in a third ... |
| 20.11.2019 | Truvian Sciences raises $27.1M for a testing system needing only “a small sample of blood” | That comparison with the now-defunct Theranos is something that the chief execute of San Diego-based Truvian Sciences is more than prepared to counter.
In response to email questions surrounding its Series B funding forwarded by a spokeswom... |
| - | Truvian Sciences raises $27.1M for a testing system needing only “a small sample of blood” | Truvian Sciences is developing an automated benchtop broad panel testing system on a “small sample of blood” to support which the company just raised $27.1 million.
How small? Seven drops to be precise. That’s six more than Theranos, which ... |
